Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 9 of 9« First...56789

France gets G7 to discuss global regulation of medicine prices

France will press its G7 partners this month to launch an “irreversible” process to control the prices of new medicines, part of a global drive to make life-saving drugs more affordable.

Read More »

Startup Homology Medicines Launches With $43 Million Series A

Startup Homology Medicines Launches With $43 Million Series A, To Be Led By Three Former Shire Execs   May 2, 2016By Mark Terry, Breaking News Staff   Lexington, Mass.-based Homology Medicines launched today with a $43.5 million Series A preferred stock financing. The round was co-led by 5AM Ventures and ARCH Venture Partners. They […]

Read More »

EMD Serono Expansion to Create 150 New Jobs in Massachusetts

May 2, 2016By Mark Terry, Breaking News Staff   EMD Serono announced today that it was building a $12 million expansion of its research-and-development facility in Billerica, Mass. EMD Serono is the U.S. subsidiary of Darmstadt, Germany-based Merck KgaA (MRK). The expansion will add 30,000 square feet to the existing space at the Sagamore […]

Read More »

Cambridge’s BIND Therapeutics Files for Chapter 11 and Reviews Strategic Alternatives

May 2, 2016 By Alex Keown, Breaking News Staff   CAMBRIDGE, Mass. – Shares of Bind Therapeutics (BIND) are down more than 64 percent this morning after BIND filed Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware, the company announced this morning. Shares of BIND are trading at 51 cents […]

Read More »

Page 9 of 9« First...56789

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom